According to key opinion leaders in biopharma cold chain, the biopharma industry is increasing its pace to prioritize sustainability in business and operational strategies. Nearly half of all respondents already always factor sustainability into cold chain purchasing decisions.
As strong growth continues across the global pharmaceuticals industry, the sub-category of temperature-controlled products is surging ahead.
Over the last decade, exciting changes have transformed the pharmaceutical industry. For example, scientific advancements, particularly those that have contributed to the rise in biologics, are increasing the complexity of patient treatments and pharmaceutical products. In addition, many manufacturers are expanding their global footprints to address unmet patient needs in smaller populations across the world.
As drug manufacturers continue to advance medicine with new discoveries in technology and science, the dominance of biologics is expected to continue, with experts predicting them to comprise more than a quarter of the pharmaceutical market by 2020.
In a critical care emergency, fast response and safe administration of blood can be the difference between life and death. Overcoming logistical issues such as how to control shelf life, how to maintain a suitable thermal environment for blood storage and transport, how to determine which patients need pre-hospital blood and what blood products to use in the pre-hospital environment are among the challenges.
It is the goal of this research to identify current packaging options that limit this environmental impact.
Active or Passive? - this White Paper gives guidance on making the optimum choice when bulk shipping temperature sensitive pharmaceutical products.